CANON COMMUNICATIONS PHARMACEUTICAL MEDIA GROUP

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 632717
                    [Title] => Novartis cited anew as most admired pharma firm
                    [Summary] => 
For the second consecutive year, readers of the respected industry publication Med Ad News have voted Novartis as the Most Admired Pharmaceutical Company for 2010.
                    [DatePublished] => 2010-11-25 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 556404
                    [Title] => Novartis drug pipeline voted industry's 'most innovative'
                    [Summary] => 
With 87 new drugs or vaccines under development and a leading focus on therapies that address rare diseases, research-based Swiss healthcare company Novartis has been selected by the pharmaceutical business and marketing news magazine Med Ad News as having the industry’s most innovative drug pipeline. 
                    [DatePublished] => 2010-03-11 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Novartis cited anew as most admired pharma firm

November 25, 2010 - 12:00am

For the second consecutive year, readers of the respected industry publication Med Ad News have voted Novartis as the Most Admired Pharmaceutical Company for 2010.

Science and Environment

Novartis drug pipeline voted industry's 'most innovative'

March 11, 2010 - 12:00am

With 87 new drugs or vaccines under development and a leading focus on therapies that address rare diseases, research-based Swiss healthcare company Novartis has been selected by the pharmaceutical business and marketing...

Science and Environment